Michael Lyman is a Senior Research Scientist at Incyte, leveraging over two decades of experience in the pharmaceutical industry, with a strong focus on Drug Metabolism and Pharmacokinetics (DMPK). Previously, they held significant roles at Merck and Exelixis Inc., where they founded a DMPK lab, enhanced project management, and managed Phase II clinical studies. Their expertise includes executing complex study designs and fostering safety and compliance in research settings. Michael earned a Bachelor of Science in Biology from Delaware Valley University and a Master of Science in Molecular Biology from Lehigh University.
Location
Pennsburg, United States
This person is not in the org chart
This person is not in any offices